当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:91.42亿  总市值:91.42亿
流通股本:17.28亿   总股本:17.28亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金42,660,741,820.7820,324,203,721.6490,100,579,625.5365,123,052,735.4
  收到的税费返还-019,160,820.086,775,661.36
  收到其他与经营活动有关的现金1,636,159,929.66437,736,013.981,125,832,292.54913,631,737.48
  经营活动现金流入小计44,296,901,750.4420,761,939,735.6291,245,572,738.1566,043,460,134.24
  购买商品、接受劳务支付的现金42,452,981,236.9621,065,437,084.9384,998,851,220.0764,843,578,501.17
  支付给职工以及为职工支付的现金951,192,706.47649,380,365.312,002,939,492.261,571,654,573.19
  支付的各项税费723,806,052.69323,651,677.631,456,966,777.871,132,002,417.82
  支付其他与经营活动有关的现金2,442,412,117.2888,007,976.182,973,552,371.091,646,492,363.11
  经营活动现金流出小计46,570,392,113.3222,926,477,104.0591,432,309,861.2969,193,727,855.29
  经营活动产生的现金流量净额-2,273,490,362.88-2,164,537,368.43-186,737,123.14-3,150,267,721.05
二、投资活动产生的现金流量:
  收回投资收到的现金--89,517,4000
  取得投资收益收到的现金119,038,363.74-95,895,035.7592,257,346.85
  处置固定资产、无形资产和其他长期资产收回的现金净额235,480.4722,701.471,397,020.111,382,394.61
  处置子公司及其他营业单位收到的现金净额399,607.57399,607.5700
  收到的其他与投资活动有关的现金19,755,717.841,078,887.1778,445,381.3457,154,427.22
  投资活动现金流入小计139,429,169.621,501,196.21265,254,837.2150,794,168.68
  购建固定资产、无形资产和其他长期资产支付的现金130,917,613.180,342,269.73250,529,897.34148,680,750.99
  投资支付的现金0048,480,00041,500,000
  质押贷款净增加额0-00
  取得子公司及其他营业单位支付的现金23,140,657.1321,988,216.53138,357,534.96137,511,186.97
  支付其他与投资活动有关的现金30,370,442.855,002,194.5510,351,467.766,499,816.89
  投资活动现金流出小计184,428,713.08107,332,680.81447,718,900.06334,191,754.85
  投资活动产生的现金流量净额-44,999,543.46-105,831,484.6-182,464,062.86-183,397,586.17
三、筹资活动产生的现金流量:
  吸收投资收到的现金19,028,83012,348,8301,050,908,745.8328,644,735.79
  其中:子公司吸收少数股东投资收到的现金19,028,83012,348,8301,050,908,745.8328,644,735.79
  取得借款收到的现金11,484,513,993.634,914,737,190.7123,783,676,955.9519,598,320,941.31
  收到其他与筹资活动有关的现金281,454,140.61261,978,671.91739,812,073.97333,421,593.66
  筹资活动现金流入小计11,784,996,964.245,189,064,692.6225,574,397,775.7519,960,387,270.76
  偿还债务支付的现金11,234,408,564.54,891,245,949.2822,902,856,190.2117,235,069,902.89
  分配股利、利润或偿付利息支付的现金551,495,180.18234,417,915.681,431,367,135.191,083,619,469.06
  其中:子公司支付给少数股东的股利、利润46,375,235.723,290,847.98311,279,316.34237,945,591.13
  支付其他与筹资活动有关的现金326,247,058.27220,706,634.391,191,840,339.45582,629,252.98
  筹资活动现金流出小计12,112,150,802.955,346,370,499.3525,526,063,664.8518,901,318,624.93
  筹资活动产生的现金流量净额-327,153,838.71-157,305,806.7348,334,110.91,059,068,645.83
五、现金及现金等价物净增加额-2,645,643,745.05-2,427,674,659.76-320,867,075.1-2,274,596,661.39
  加:期初现金及现金等价物余额4,786,982,574.244,786,982,574.245,107,849,649.345,107,849,649.34
  期末现金及现金等价物余额2,141,338,829.192,359,307,914.484,786,982,574.242,833,252,987.95
补充资料:
  净利润388,988,353.43-401,791,459.73-
  资产减值准备2,991,945.06-613,983,762.51-
  固定资产和投资性房地产折旧122,708,600.9-233,329,033.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧122,708,600.9-233,329,033.85-
  无形资产摊销25,054,788.76-30,189,584.52-
  长期待摊费用摊销31,385,670.99-76,800,645.3-
  处置固定资产、无形资产和其他长期资产的损失-1,202,756.45--10,534,476.58-
  固定资产报废损失---12,467.97-
  公允价值变动损失861,030.74--6,919,028.26-
  财务费用379,653,270.8-1,137,829,179.76-
  投资损失-58,201,620.47--402,412,494.38-
  递延所得税-26,032,430.08--96,496,331.85-
  其中:递延所得税资产减少-24,964,750.86--110,203,746.04-
    递延所得税负债增加-1,067,679.22-13,707,414.19-
  存货的减少-315,335,259.71--1,432,255,263.76-
  经营性应收项目的减少-3,335,799,063.08--1,662,828,988.31-
  经营性应付项目的增加711,018,620.83-728,597,767.63-
  其他-299,209,682.74---
  现金的期末余额2,141,338,829.19-4,786,982,574.24-
  减:现金的期初余额4,786,982,574.24-5,107,849,649.34-
  加:现金等价物的期末余额0---
  减:现金等价物的期初余额0---
  现金及现金等价物的净增加额-2,645,643,745.05--320,867,075.1-
公告日期2025-08-212025-04-242025-04-242024-10-25
审计意见(境内)标准无保留意见
TOP↑